Palvella Therapeutics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$9,704,572
13 notices · 75,197 sh
Oct 2025 to Oct 2026
Reported ·
$3,554,577
21 sales · 3 buys · $849,974 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
All 21 reported sales carry the 10b5-1 box. Together they are 0.24% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-16Goin Kathleen, Chief Operating Officer$650,548
2026-09-11JENKINS GEORGE M, Director$4,135,725
2026-09-02CHRISTOPHER KIRITSY, Director$58,875
2026-08-19Goin Kathleen, Chief Operating Officer$647,107
2026-07-15Goin Kathleen, Chief Operating Officer$643,923
2026-06-17Goin Kathleen, Chief Operating Officer$476,373
Form 4, 2026-06-22: sold 4,302 at $110.73 Form 4 ↗
2026-05-20Goin Kathleen, Chief Operating Officer$475,631
Form 4, 2026-05-22: sold 4,302 at $110.56 Form 4 ↗
2026-04-15Goin Kathleen, Chief Operating Officer$557,238
Form 4, 2026-04-17: sold 4,302 at $127.24 Form 4 ↗
2026-03-18Goin Kathleen, Chief Operating Officer$519,681
Form 4, 2026-03-20: sold 4,302 at $117.99 Form 4 ↗
2026-02-18Goin Kathleen, Chief Operating Officer$344,547
Form 4, 2026-02-20: sold 4,302 at $79.40 Form 4 ↗
2026-01-21Goin Kathleen, Chief Operating Officer$421,639
Form 4, 2026-01-23: sold 4,302 at $97.63 Form 4 ↗
2025-12-17Goin Kathleen, Chief Operating Officer$416,477
Form 4, 2025-12-19: sold 4,302 at $96.47 Form 4 ↗